At this year’s AAO, visitors, both virtual and in-person, can expect to learn about all the latest products Quidel has to offer the eyecare space. This includes the latest data on our flagship product, Inflammadry, the only affordable MMP9 test to detect inflammation on the ocular surface. In addition, we will introduce new product offerings addressing the current needs of our customers’ practices and surgery centers. They are designed to ensure the safety of patients and staff so that clinics can remain open.
Over the past 18 months, we have had to adapt the way we conduct business with our customers. The “hybrid” approach to business has forced us to become more efficient working from home in our new virtual environment. It has also helped us expand our international business, both with our current distributors and new distribution relationships in existing and new markets.
Quidel is looking forward to getting back to a live inperson meeting at the AAO. We have spent many years building strong partnerships in this business and we are long overdue getting closer to “business as usual” in New Orleans.We plan to host a Dry Eye Roundtable featuring prominent KOLs in the industry discussing the most recent approach to OSD management as oulined in the 2019 ASCRS Guidelines. In addition, we will have several experts in the field at our booth to share successes in their practices. We will also offer live training sessions on Inflammadry and COVID-19-safe environment.
Booth number 1034
